High levels of HCV core+1 antibodies in HCV patients with hepatocellular carcinoma

Journal of General Virology

Volumn 92, Issue 6, 2011, Pages 1343-1351

  Dalagiorgou, G ^a,b   Vassilaki, N ^a   Foka, P ^a   Boumlic, A ^a,c   Kakkanas, A ^a   Kochlios, E ^a   Khalili, S ^a   Aslanoglou, E ^a   Veletza, S ^b   Orfanoudakis, G ^c   Vassilopoulos, D ^d   Hadziyannis, S J ^e   Koskinas, J ^f   Mavromara, P ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e HENRY DUNANT HOSPITAL   (Greece)

^f HIPPOKRATION HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; HISTIDINE; RECOMBINANT PROTEIN;

ANTIBODY DETECTION; ARTICLE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; VIRUS GENOME; VIRUS HEPATITIS; VIRUS REPLICATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS;

EID: 79956332883     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.023010-0     Document Type: Article

References (44)

1. Bain, C., Parroche, P., Lavergne, J. P., Duverger, B., Vieux, C., Dubois, V., Komurian-Pradel, F., Trépo, C., Gebuhrer, L. & other authors (2004). Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection. J Virol 78, 10460-10469.
2. Baril, M. & Brakier-Gingras, L. (2005). Translation of the F protein of hepatitis C virus is initiated at a non-AUG codon in a +1 reading frame relative to the polyprotein. Nucleic Acids Res 33, 1474-1486.
3. Bartenschlager, R., Frese, M. & Pietschmann, T. (2004). Novel insights into hepatitis C virus replication and persistence. Adv Virus Res 63, 71-180.
4. Basu, A., Steele, R., Ray, R. & Ray, R. B. (2004). Functional properties of a 16 kDa protein translated from an alternative open reading frame of the core-encoding genomic region of hepatitis C virus. J Gen Virol 85, 2299-2306.
5. Boulant, S., Becchi, M., Penin, F. & Lavergne, J. P. (2003). Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b. J Biol Chem 278, 45785-45792.
6. Boumlic, A., Nominé, Y., Charbonnier, S., Dalagiorgou, G., Vassilaki, N., Kieffer, B., Travé, G., Mavromara, P. & Orfanoudakis, G. (2010). Prevalence of intrinsic disorder in the hepatitis C virus ARFP/Core+1/S protein. FEBS J 277, 774-789.
7. Boumlic, A., Vassilaki, N., Dalagiorgou, G., Kochlios, E., Kakkanas, A., Georgopoulou, U., Markoulatos, P., Orfanoudakis, G. & Mavromara, P. (2011). Internal translation initiation stimulates expression of the ARF/core+1 open reading frame of HCV genotype 1b. Virus Res 155, 213-220.
8. Branch, A. D., Stump, D. D., Gutierrez, J. A., Eng, F. & Walewski, J. L. (2005). The hepatitis C virus alternate reading frame (ARF) and its family of novel products: the alternate reading frame protein/F-protein, the double-frameshift protein, and others. Semin Liver Dis 25, 105-117.
9. Choi, J., Xu, Z. & Ou, J. H. (2003). Triple decoding of hepatitis C virus RNA by programmed translational frameshifting. Mol Cell Biol 23, 1489-1497.
10. Chuang, W. C. & Allain, J. P. (2008). Differential reactivity of putative genotype 2 hepatitis C virus F protein between chronic and recovered infections. J Gen Virol 89, 1890-1900.
11. Cohen, M., Bachmatov, L., Ben-Ari, Z., Rotman, Y., Tur-Kaspa, R. & Zemel, R. (2007). Development of specific antibodies to an ARF protein in treated patients with chronic HCV infection. Dig Dis Sci 52, 2427-2432.
12. di Bisceglie, A. M. (2000). Natural history of hepatitis C: its impact on clinical management. Hepatology 31, 1014-1018.
13. Eng, F. J., Walewski, J. L., Klepper, A. L., Fishman, S. L., Desai, S. M., McMullan, L. K., Evans, M. J., Rice, C. M. & Branch, A. D. (2009). Internal initiation stimulates production of p8 minicore, a member of a newly discovered family of hepatitis C virus core protein isoforms. J Virol 83, 3104-3114.
14. Fiorucci, M., Boulant, S., Fournillier, A., Abraham, J. D., Lavergne, J. P., Paranhos-Baccala, G., Inchauspé, G. & Bain, C. (2007). Expression of the alternative reading frame protein of hepatitis C virus induces cytokines involved in hepatic injuries. J Gen Virol 88, 1149-1162.
15. Fishman, S. L., Factor, S. H., Balestrieri, C., Fan, X., Dibisceglie, A. M., Desai, S. M., Benson, G. & Branch, A. D. (2009). Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma. Clin Cancer Res 15, 3205-3213.
16. Hoofnagle, J. H. (2002). Course and outcome of hepatitis C. Hepatology 36 (Suppl. 1), S21-S29.
17. Houghton, M. & Abrignani, S. (2005). Prospects for a vaccine against the hepatitis C virus. Nature 436, 961-966.
18. Ikeda, K., Saitoh, S., Koida, I., Arase, Y., Tsubota, A., Chayama, K., Kumada, H. & Kawanishi, M. (1993). A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18, 47-53.
19. Kalamvoki, M., Georgopoulou, U. & Mavromara, P. (2006). The NS5A protein of the hepatitis C virus genotype 1a is cleaved by caspases to produce C-terminal-truncated forms of the protein that reside mainly in the cytosol. J Biol Chem 281, 13449-13462.
20. Komurian-Pradel, F., Rajoharison, A., Berland, J. L., Khouri, V., Perret, M., Van Roosmalen, M., Pol, S., Negro, F. & Paranhos-Baccalà, G. (2004). Antigenic relevance of F protein in chronic hepatitis C virus infection. Hepatology 40, 900-909.
21. Lemon, S. M., Lerat, H., Weinman, S. A. & Honda, M. (2000). A transgenic mouse model of steatosis and hepatocellular carcinoma associated with chronic hepatitis C virus infection in humans. Trans Am Clin Climatol Assoc 111, 146-156, discussion 156-157.
22. Lerat, H., Honda, M., Beard, M. R., Loesch, K., Sun, J., Yang, Y., Okuda, M., Gosert, R., Xiao, S. Y. & Weinman, S. (2002). Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 122, 352-365.
23. McMullan, L. K., Grakoui, A., Evans, M. J., Mihalik, K., Puig, M., Branch, A. D., Feinstone, S. M. & Rice, C. M. (2007). Evidence for a functional RNA element in the hepatitis C virus core gene. Proc Natl Acad Sci U S A 104, 2879-2884.
24. Moradpour, D., Penin, F. & Rice, C. M. (2007). Replication of hepatitis C virus. Nat Rev Microbiol 5, 453-463.
25. Morice, Y., Ratinier, M., Miladi, A., Chevaliez, S., Germanidis, G., Wedemeyer, H., Laperche, S., Lavergne, J. P. & Pawlotsky, J. M. (2009). Seroconversion to hepatitis C virus alternate reading frame protein during acute infection. Hepatology 49, 1449-1459.
26. Pavio, N., Battaglia, S., Boucreux, D., Arnulf, B., Sobesky, R., Hermine, O. & Brechot, C. (2005). Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-b pathway. Oncogene 24, 6119-6132.
27. Pawlotsky, J. M., Morice, Y., Miladi, A., Lavergne, J., Germanidis, G. & Penin, F. (2005). Seroconversion profiles against alternative frameshift protein F of Hepatitis C virus in acute phase infection from unique sources demonstrates F protein production and points to differential expression in different patients. In 12th International Symposium on HCV and Related Viruses, Montreal, Quebec, Canada.
28. Simmonds, P. (1995). Variability of hepatitis C virus. Hepatology 21, 570-583.
29. Simmonds, P., Bukh, J., Combet, C., Deléage, G., Enomoto, N., Feinstone, S., Halfon, P., Inchauspé, G., Kuiken, C. & other authors (2005). Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42, 962-973.
30. Smith, D. B. & Simmonds, P. (1997). Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J Mol Evol 45, 238-246.
31. Sobesky, R., Feray, C., Rimlinger, F., Derian, N., Dos Santos, A., Roque-Afonso, A. M., Samuel, D., Bréchot, C. & Thiers, V. (2007). Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection. Hepatology 46, 1704-1712.
32. Troesch, M., Jalbert, E., Canobio, S., Boulassel, M. R., Routy, J. P., Bernard, N. F., Bruneau, J., Lapointe, N., Boucher, M. & Soudeyns, H. (2005). Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1. AIDS 19, 775-784.
33. Tsao, M. L., Chao, C. H. & Yeh, C. T. (2006). Interaction of hepatitis C virus F protein with prefoldin 2 perturbs tubulin cytoskeleton organization. Biochem Biophys Res Commun 348, 271-277.
34. van Regenmortel, M. H., Mayo, M. A., Fauquet, C. M. & Maniloff, J. (2000). Virus nomenclature: consensus versus chaos. Arch Virol 145, 2227-2232.
35. Varaklioti, A., Vassilaki, N., Georgopoulou, U. & Mavromara, P. (2002). Alternate translation occurs within the core coding region of the hepatitis C viral genome. J Biol Chem 277, 17713-17721.
36. Vassilaki, N. & Mavromara, P. (2003). Two alternative translation mechanisms are responsible for the expression of the HCV ARFP/F/ core+1 coding open reading frame. J Biol Chem 278, 40503-40513.
37. Vassilaki, N. & Mavromara, P. (2009). The HCV ARFP/F/core+1 protein: production and functional analysis of an unconventional viral product. IUBMB Life 61, 739-752.
38. Vassilaki, N., Boleti, H. & Mavromara, P. (2007). Expression studies of the core+1 protein of the hepatitis C virus 1a in mammalian cells. The influence of the core protein and proteasomes on the intracellular levels of core+1. FEBS J 274, 4057-4074.
39. Vassilaki, N., Boleti, H. & Mavromara, P. (2008a). Expression studies of the HCV-1a core+1 open reading frame in mammalian cells. Virus Res 133, 123-135.
40. Vassilaki, N., Friebe, P., Meuleman, P., Kallis, S., Kaul, A., Paranhos-Baccalá, G., Leroux-Roels, G., Mavromara, P. & Bartenschlager, R. (2008b). Role of the hepatitis C virus core+1 open reading frame and core cis-acting RNA elements in viral RNA translation and replication. J Virol 82, 11503-11515.
41. Vassilaki, N., Kalliampakou, K. I. & Mavromara, P. (2008c). Differences in the expression of the hepatitis C virus core+1 open reading frame between a nuclear and a cytoplasmic expression system. J Gen Virol 89, 222-231.
42. Walewski, J. L., Keller, T. R., Stump, D. D. & Branch, A. D. (2001). Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA 7, 710-721.
43. Wu, W. B., Shao, S. W., Zhao, L. J., Luan, J., Cao, J., Gao, J., Zhu, S. Y. & Qi, Z. T. (2007). Hepatitis C virus F protein up-regulates c-myc and down-regulates p53 in human hepatoma HepG2 cells. Intervirology 50, 341-346.
44. Xu, Z., Choi, J., Yen, T. S., Lu, W., Strohecker, A., Govindarajan, S., Chien, D., Selby, M. J. & Ou, J. (2001). Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J 20, 3840-3848.